Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in EQ — Equillium, Inc.

CIK 1214717 BOSTON, MA
Back to EQ Full portfolio

Position in EQ

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,219,759
+$462,133 QoQ
Shares Held
381,175
+0.6% QoQ
Ownership
0.601%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 60 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EQ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. EQ ranks #309 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in EQ

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,219,759 381,175
2026-03-31 $757,626 378,813
2025-12-31 $535,230 345,310
2025-09-30 $444,471 310,819
2025-06-30 $62,748 196,091
2025-03-31 $80,092 205,367
2024-12-31 $153,288 204,385
2024-09-30 $169,638 204,385
2024-06-30 $149,180 216,204
2024-03-31 $461,371 199,728
2023-12-31 $124,118 172,387
2023-09-30 $127,566 172,387
2023-06-30 $119,082 158,777
2023-03-31 $115,907 158,777
2022-12-31 $168,303 158,777
2022-09-30 $353,313 159,150
2022-06-30 $324,666 159,150
2022-03-31 $495,249 157,222
2021-12-31 $581,277 154,185
2021-09-30 $1,051,541 154,185
2021-06-30 $886,927 150,582
2021-03-31 $922,864 129,072
2020-12-31 $347,065 64,872
2020-09-30 $264,196 45,788